Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nanalysis Scientific ( (TSE:NSCI) ) just unveiled an update.
Nanalysis Scientific Corp. reported a challenging second quarter for 2025, with a 17% decline in revenue primarily due to reduced product sales amidst global economic uncertainty and tariff risks. Despite these challenges, the company achieved improved gross margins in its scientific equipment business through cost reduction and efficiency measures, and saw a 7% increase in security services revenue. The company remains committed to operational efficiency and long-term growth, with ongoing efforts to enhance margins and manage costs effectively.
More about Nanalysis Scientific
Nanalysis Scientific Corp. is a leader in the development of portable NMR spectrometers and MRI technology, catering to both industrial and research applications. The company is focused on building a vertically integrated scientific instrumentation business, advancing its Benchtop NMR platforms, and strengthening its service offerings.
Average Trading Volume: 115,601
Technical Sentiment Signal: Sell
Current Market Cap: C$25.84M
See more insights into NSCI stock on TipRanks’ Stock Analysis page.